28-06-2017
carmendorin / iStockphoto.com
The US Food and Drug Administration (FDA) has revealed plans to increase competition in the US market for prescription drugs, as well as to facilitate the entry of generic drugs into the market.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, generics, ANDA, policy, competition, Scott Gottlieb, Food and Drug Administration, off-patent, patent, branded drugs, medicines
